Functionally-claimed antibody patent – the Amgen v Sanofi case
Practices:Intellectual Property、Patents
Category:Others
| Authors | YAMAMOTO, Osamu |
|---|---|
| Practice Areas | Intellectual Property Patents |
| Date of publication | Issue 1 2020 |
| Publication carrying this article | The Life Sciences Lawyer（P46～48） |
| Publisher | CTC Legal Media |
Summary
Mr. Yamamoto analyzes the functionally-claimed antibody patent cases between Amgen and Sanofi in Japan.
Other works by YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Cases
Antibody Patenting – Second Edition –
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
Pharmaceutical Test Data Exclusivity
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
IP law in Japan : the recent changes
YAMAMOTO, Osamu
-
Publications
2022 – Study Question “Patentability of Diagnostic Methods”
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Others
Japanese version of “Amicus Curiae”
YAMAMOTO, Osamu
Other works on Intellectual Property、Patents
-
Publications Intellectual Property、Trademarks
Trademark Case No.83 The “Nepal Tiger” case（Consideration of Descriptive Trademarks, Comparison with the “Tibet Tiger” and “hololive Indonesia” Cases)
SUMITANI, Yuji
-
Publications Copyright Law、Intellectual Property、Patents、Trademarks
Q&A Practice for Prevention and Treatment of Intellectual Property Troubles “Cross License Agreements – Strategic Use and Legal Considerations “
SUMITANI, Yuji
-
Publications Intellectual Property、Patents Laws
Damage Claims for Patent Infringement by a Patentee’s Group Company
FUKAI, Toshiyuki
-
Publications Intellectual Property、Patents Laws
The Wording of Injunctions in Patent Infringement Litigation
FUKAI, Toshiyuki
-
Publications Copyright Law、Intellectual Property Laws
Utilization of a Copyrightable Work as a “Quotation”
FUKAI, Toshiyuki
Telephone
+81(3)3270-6641